NIH awards $135.9M contract for Biomedical Research and Development to Icahn School of Medicine
Contract Overview
Contract Amount: $13,590,828 ($13.6M)
Contractor: Icahn School of Medicine AT Mount Sinai
Awarding Agency: Department of Health and Human Services
Start Date: 2005-09-30
End Date: 2011-03-31
Contract Duration: 2,008 days
Daily Burn Rate: $6.8K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 21
Pricing Type: COST NO FEE
Sector: R&D
Official Description: BIOMEDICAL (BASIC)
Place of Performance
Location: NEW YORK, NEW YORK County, NEW YORK, 10029
State: New York Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $13.6 million to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI for work described as: BIOMEDICAL (BASIC) Key points: 1. The contract value of $135.9 million over its period of performance is substantial. 2. The award was made under full and open competition, indicating a competitive bidding process. 3. The contract type is 'Cost No Fee', which shifts risk to the government. 4. The sector is R&D, specifically in Physical, Engineering, and Life Sciences.
Value Assessment
Rating: fair
The 'Cost No Fee' contract type suggests the government bears the financial risk if costs exceed estimates. Without fee, the incentive for cost control is reduced. The benchmark for similar R&D contracts would need to consider the specific research scope and duration.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting a robust price discovery process. This method typically leads to more competitive pricing as multiple vendors can bid.
Taxpayer Impact: The competitive nature of the award is positive for taxpayers, likely resulting in a fair market price for the research services.
Public Impact
Significant federal investment in biomedical research supports scientific advancement. The contract duration and value indicate a long-term commitment to a specific research area. Funding for research at academic institutions like Icahn School of Medicine can foster innovation and economic growth.
Waste & Efficiency Indicators
Waste Risk Score: 67 / 10
Warning Flags
- Cost No Fee contract type increases government risk.
- Long contract duration may not adapt to evolving research needs.
Positive Signals
- Awarded under full and open competition.
- Significant investment in a critical R&D sector.
Sector Analysis
This contract falls within the R&D sector, specifically focusing on physical, engineering, and life sciences. Federal spending in this area is crucial for scientific discovery and technological advancement, with benchmarks varying widely based on research scope and duration.
Small Business Impact
The data does not indicate whether small businesses were involved in this contract. Further analysis would be needed to determine the extent of small business participation.
Oversight & Accountability
The contract was awarded by the National Institutes of Health (NIH), a component of HHS, suggesting established oversight mechanisms. However, the 'Cost No Fee' structure warrants close monitoring of expenditures.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Cost No Fee contract type.
- Long contract duration.
- Potential for scope creep in R&D.
- Reliance on a single institution for a large sum.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, ny, definitive-contract, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $13.6 million to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. BIOMEDICAL (BASIC)
Who is the contractor on this award?
The obligated recipient is ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $13.6 million.
What is the period of performance?
Start: 2005-09-30. End: 2011-03-31.
What specific research outcomes are expected from this $135.9 million investment, and how will their achievement be measured?
The contract's objective is likely to advance fundamental knowledge in biomedical sciences. Specific outcomes would be detailed in the Statement of Work, including milestones for data collection, analysis, and publication. Success metrics would focus on the progress towards these defined research goals and the scientific merit of the findings, rather than a fixed deliverable.
Given the 'Cost No Fee' structure, what controls are in place to manage potential cost overruns and ensure efficient use of funds?
While 'Cost No Fee' shifts risk to the government, NIH likely employs stringent financial monitoring. This includes regular reviews of incurred costs, progress reports tied to expenditures, and adherence to the approved research plan. The agency may also have mechanisms for de-obligation if research progress stalls or funds are mismanaged.
How does the chosen research institution's track record and specific expertise align with the stated goals of the NIH in this biomedical area?
The NIH's selection of the Icahn School of Medicine suggests a thorough evaluation of their scientific merit, existing infrastructure, and relevant expertise. Their past performance in similar research areas, publication record, and the proposed research team's qualifications would have been critical factors in the competitive award process.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: BASIC RESEARCH
Offers Received: 21
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Parent Company: Mount Sinai Hospital
Address: 1 GUSTAVE L LEVY PL, NEW YORK, NY, 10029
Business Categories: Category Business, Educational Institution, Higher Education, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $18,691,713
Exercised Options: $13,590,828
Current Obligation: $13,590,828
Contract Characteristics
Multi-Year Contract: Yes
Commercial Item: COMMERCIAL ITEM PROCEDURES NOT USED
Timeline
Start Date: 2005-09-30
Current End Date: 2011-03-31
Potential End Date: 2011-03-31 00:00:00
Last Modified: 2024-11-23
More Contracts from Icahn School of Medicine AT Mount Sinai
- Wtchp Clinical Center of Excellence — $151.5M (Department of Health and Human Services)
- World Trade Center Health Program Clinical Center of Excellence Services — $129.5M (Department of Health and Human Services)
- This Contract Will Support Component a of the Collaborative Influenza Vaccine Innovation Centers (civics) Program to Design and Evaluate Innovative Influenza Vaccine Approaches, Based on Principles of Influenza Immunity, That Achieve Durable, Robust — $107.5M (Department of Health and Human Services)
- World Trade Center Health Care Program — $82.7M (Department of Health and Human Services)
- Niaid Centers of Excellence for Influenza Research and Surveillance (ceirs) — $79.8M (Department of Health and Human Services)
View all Icahn School of Medicine AT Mount Sinai federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →